Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates

Inflammation and immune activation of the cervicovaginal mucosa are considered factors that increase susceptibility to HIV infection. Therefore, it is essential to screen candidate anti-HIV microbicides for potential mucosal immunomodulatory/inflammatory effects prior to further clinical development...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2015-06, Vol.10 (6), p.e0128557-e0128557
Hauptverfasser: Zalenskaya, Irina A, Joseph, Theresa, Bavarva, Jasmin, Yousefieh, Nazita, Jackson, Suzanne S, Fashemi, Titilayo, Yamamoto, Hidemi S, Settlage, Robert, Fichorova, Raina N, Doncel, Gustavo F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0128557
container_issue 6
container_start_page e0128557
container_title PloS one
container_volume 10
creator Zalenskaya, Irina A
Joseph, Theresa
Bavarva, Jasmin
Yousefieh, Nazita
Jackson, Suzanne S
Fashemi, Titilayo
Yamamoto, Hidemi S
Settlage, Robert
Fichorova, Raina N
Doncel, Gustavo F
description Inflammation and immune activation of the cervicovaginal mucosa are considered factors that increase susceptibility to HIV infection. Therefore, it is essential to screen candidate anti-HIV microbicides for potential mucosal immunomodulatory/inflammatory effects prior to further clinical development. The goal of this study was to develop an in vitro method for preclinical evaluation of the inflammatory potential of new candidate microbicides using a microarray gene expression profiling strategy. To this end, we compared transcriptomes of human vaginal cells (Vk2/E6E7) treated with well-characterized pro-inflammatory (PIC) and non-inflammatory (NIC) compounds. PICs included compounds with different mechanisms of action. Gene expression was analyzed using Affymetrix U133 Plus 2 arrays. Data processing was performed using GeneSpring 11.5 (Agilent Technologies, Santa Clara, CA). Microarraray comparative analysis allowed us to generate a panel of 20 genes that were consistently deregulated by PICs compared to NICs, thus distinguishing between these two groups. Functional analysis mapped 14 of these genes to immune and inflammatory responses. This was confirmed by the fact that PICs induced NFkB pathway activation in Vk2 cells. By testing microbicide candidates previously characterized in clinical trials we demonstrated that the selected PIC-associated genes properly identified compounds with mucosa-altering effects. The discriminatory power of these genes was further demonstrated after culturing vaginal cells with vaginal bacteria. Prevotella bivia, prevalent bacteria in the disturbed microbiota of bacterial vaginosis, induced strong upregulation of seven selected PIC-associated genes, while a commensal Lactobacillus gasseri associated to vaginal health did not cause any changes. In vitro evaluation of the immunoinflammatory potential of microbicides using the PIC-associated genes defined in this study could help in the initial screening of candidates prior to entering clinical trials. Additional characterization of these genes can provide further insight into the cervicovaginal immunoinflammatory and mucosal-altering processes that facilitate or limit HIV transmission with implications for the design of prevention strategies.
doi_str_mv 10.1371/journal.pone.0128557
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1686781330</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A417147678</galeid><doaj_id>oai_doaj_org_article_09b02aa94a424870a29f674be840edd1</doaj_id><sourcerecordid>A417147678</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-88af4ab91d205231991849e70c0be90e67c6e11a8c2751a5881d8147f01d85073</originalsourceid><addsrcrecordid>eNqNk91u0zAUxyMEYmPwBggsISG4aLHzZYcLpFHGVmljCMZurVPnpPVI4mI7Y3tJnonTrZtWtAuUC0f27_zPd5I8F3wsMinenbnB99COl67HMRepKgr5INkWVZaOypRnD-_8byVPQjjjvMhUWT5OttKSF2mVltvJn33ske1dLD2GYF3PvnrX2Nb2c-YadjB00LNTmFvyxCbYtoFN6cJG79gnG4y3HT1FDGziuqUb-jqw3zYuVjKjad-00HUQnb9k0NfsaDAuwGi3jehXHghaoo8Ww3v2xZ1jyz5a14H_iT6wxnkC0FAs1pD3EwzxJqzpKTuyxruZNbZGNiFxW6_CeJo8aqAN-Gx97iQ_Pu-dTA5Gh8f708nu4ciUVRpHSkGTw6wSdUqFyERVCZVXKLnhM6w4ltKUKAQok8pCQKGUqJXIZcPpLLjMdpKX17rL1gW9bkXQolSlVCLLOBHTa6J2cKaXVCjwl9qB1VcXzs81UOqmRc2rGU8BqhzyNFeSQ1o1pcxnqHKOdS1I68Pa2zDrsDbYRw_thujmS28Xeu7OdZ4XlZKKBN6sBbz7NVAhdUfNo3ZCj264iltmJY1VReirf9D7s1tTc6AEbN848mtWono3F5JKVV65Hd9D0VdjZw3NLU0abhq83TAgJuJFnMMQgp5-__b_7PHpJvv6DrtAaOMiuHaINPFhE8yvQRquEDw2t0UWXK_W7qYaerV2er12ZPbiboNujW72LPsLM-IqKQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1686781330</pqid></control><display><type>article</type><title>Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Zalenskaya, Irina A ; Joseph, Theresa ; Bavarva, Jasmin ; Yousefieh, Nazita ; Jackson, Suzanne S ; Fashemi, Titilayo ; Yamamoto, Hidemi S ; Settlage, Robert ; Fichorova, Raina N ; Doncel, Gustavo F</creator><contributor>Garcia-Lerma, J. Gerardo</contributor><creatorcontrib>Zalenskaya, Irina A ; Joseph, Theresa ; Bavarva, Jasmin ; Yousefieh, Nazita ; Jackson, Suzanne S ; Fashemi, Titilayo ; Yamamoto, Hidemi S ; Settlage, Robert ; Fichorova, Raina N ; Doncel, Gustavo F ; Garcia-Lerma, J. Gerardo</creatorcontrib><description>Inflammation and immune activation of the cervicovaginal mucosa are considered factors that increase susceptibility to HIV infection. Therefore, it is essential to screen candidate anti-HIV microbicides for potential mucosal immunomodulatory/inflammatory effects prior to further clinical development. The goal of this study was to develop an in vitro method for preclinical evaluation of the inflammatory potential of new candidate microbicides using a microarray gene expression profiling strategy. To this end, we compared transcriptomes of human vaginal cells (Vk2/E6E7) treated with well-characterized pro-inflammatory (PIC) and non-inflammatory (NIC) compounds. PICs included compounds with different mechanisms of action. Gene expression was analyzed using Affymetrix U133 Plus 2 arrays. Data processing was performed using GeneSpring 11.5 (Agilent Technologies, Santa Clara, CA). Microarraray comparative analysis allowed us to generate a panel of 20 genes that were consistently deregulated by PICs compared to NICs, thus distinguishing between these two groups. Functional analysis mapped 14 of these genes to immune and inflammatory responses. This was confirmed by the fact that PICs induced NFkB pathway activation in Vk2 cells. By testing microbicide candidates previously characterized in clinical trials we demonstrated that the selected PIC-associated genes properly identified compounds with mucosa-altering effects. The discriminatory power of these genes was further demonstrated after culturing vaginal cells with vaginal bacteria. Prevotella bivia, prevalent bacteria in the disturbed microbiota of bacterial vaginosis, induced strong upregulation of seven selected PIC-associated genes, while a commensal Lactobacillus gasseri associated to vaginal health did not cause any changes. In vitro evaluation of the immunoinflammatory potential of microbicides using the PIC-associated genes defined in this study could help in the initial screening of candidates prior to entering clinical trials. Additional characterization of these genes can provide further insight into the cervicovaginal immunoinflammatory and mucosal-altering processes that facilitate or limit HIV transmission with implications for the design of prevention strategies.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0128557</identifier><identifier>PMID: 26052926</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Activation ; Anti-Infective Agents - pharmacology ; Anti-Infective Agents - therapeutic use ; Bacteria ; Bacteria - drug effects ; Bacteria - growth &amp; development ; Bioinformatics ; Biology ; Biomarkers ; Biomarkers - metabolism ; Cancer ; Cell Line ; Cellulose ; Clinical trials ; Cluster Analysis ; Colony Count, Microbial ; Comparative analysis ; Data processing ; Deregulation ; Disease transmission ; DNA microarrays ; Drug Evaluation, Preclinical ; Evaluation ; Female ; Functional analysis ; Gene expression ; Gene Expression Profiling ; Gene Regulatory Networks - drug effects ; Genes ; Gynecology ; Health aspects ; HIV ; HIV infections ; HIV Infections - drug therapy ; Human immunodeficiency virus ; Humans ; Immune response ; Immunologic Factors - pharmacology ; Immunomodulation ; In vitro methods and tests ; Infections ; Inflammation ; Inflammation - pathology ; Laboratories ; Lymphocytes ; Medical research ; Medical schools ; Microbial Sensitivity Tests ; Microbicides ; Microbiota ; Microbiota (Symbiotic organisms) ; Models, Biological ; Mucosa ; Mucous Membrane - drug effects ; Mucous Membrane - pathology ; NF-kappa B - metabolism ; NF-κB protein ; Obstetrics ; Oligonucleotide Array Sequence Analysis ; Real-Time Polymerase Chain Reaction ; Reproducibility of Results ; Risk factors ; Transcription, Genetic - drug effects ; Vagina ; Vagina - cytology ; Vagina - microbiology ; Vaginosis ; Young adults</subject><ispartof>PloS one, 2015-06, Vol.10 (6), p.e0128557-e0128557</ispartof><rights>COPYRIGHT 2015 Public Library of Science</rights><rights>2015 Zalenskaya et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Zalenskaya et al 2015 Zalenskaya et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-88af4ab91d205231991849e70c0be90e67c6e11a8c2751a5881d8147f01d85073</citedby><cites>FETCH-LOGICAL-c692t-88af4ab91d205231991849e70c0be90e67c6e11a8c2751a5881d8147f01d85073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459878/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459878/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2101,2927,23865,27923,27924,53790,53792,79471,79472</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26052926$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Garcia-Lerma, J. Gerardo</contributor><creatorcontrib>Zalenskaya, Irina A</creatorcontrib><creatorcontrib>Joseph, Theresa</creatorcontrib><creatorcontrib>Bavarva, Jasmin</creatorcontrib><creatorcontrib>Yousefieh, Nazita</creatorcontrib><creatorcontrib>Jackson, Suzanne S</creatorcontrib><creatorcontrib>Fashemi, Titilayo</creatorcontrib><creatorcontrib>Yamamoto, Hidemi S</creatorcontrib><creatorcontrib>Settlage, Robert</creatorcontrib><creatorcontrib>Fichorova, Raina N</creatorcontrib><creatorcontrib>Doncel, Gustavo F</creatorcontrib><title>Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Inflammation and immune activation of the cervicovaginal mucosa are considered factors that increase susceptibility to HIV infection. Therefore, it is essential to screen candidate anti-HIV microbicides for potential mucosal immunomodulatory/inflammatory effects prior to further clinical development. The goal of this study was to develop an in vitro method for preclinical evaluation of the inflammatory potential of new candidate microbicides using a microarray gene expression profiling strategy. To this end, we compared transcriptomes of human vaginal cells (Vk2/E6E7) treated with well-characterized pro-inflammatory (PIC) and non-inflammatory (NIC) compounds. PICs included compounds with different mechanisms of action. Gene expression was analyzed using Affymetrix U133 Plus 2 arrays. Data processing was performed using GeneSpring 11.5 (Agilent Technologies, Santa Clara, CA). Microarraray comparative analysis allowed us to generate a panel of 20 genes that were consistently deregulated by PICs compared to NICs, thus distinguishing between these two groups. Functional analysis mapped 14 of these genes to immune and inflammatory responses. This was confirmed by the fact that PICs induced NFkB pathway activation in Vk2 cells. By testing microbicide candidates previously characterized in clinical trials we demonstrated that the selected PIC-associated genes properly identified compounds with mucosa-altering effects. The discriminatory power of these genes was further demonstrated after culturing vaginal cells with vaginal bacteria. Prevotella bivia, prevalent bacteria in the disturbed microbiota of bacterial vaginosis, induced strong upregulation of seven selected PIC-associated genes, while a commensal Lactobacillus gasseri associated to vaginal health did not cause any changes. In vitro evaluation of the immunoinflammatory potential of microbicides using the PIC-associated genes defined in this study could help in the initial screening of candidates prior to entering clinical trials. Additional characterization of these genes can provide further insight into the cervicovaginal immunoinflammatory and mucosal-altering processes that facilitate or limit HIV transmission with implications for the design of prevention strategies.</description><subject>Activation</subject><subject>Anti-Infective Agents - pharmacology</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Bacteria</subject><subject>Bacteria - drug effects</subject><subject>Bacteria - growth &amp; development</subject><subject>Bioinformatics</subject><subject>Biology</subject><subject>Biomarkers</subject><subject>Biomarkers - metabolism</subject><subject>Cancer</subject><subject>Cell Line</subject><subject>Cellulose</subject><subject>Clinical trials</subject><subject>Cluster Analysis</subject><subject>Colony Count, Microbial</subject><subject>Comparative analysis</subject><subject>Data processing</subject><subject>Deregulation</subject><subject>Disease transmission</subject><subject>DNA microarrays</subject><subject>Drug Evaluation, Preclinical</subject><subject>Evaluation</subject><subject>Female</subject><subject>Functional analysis</subject><subject>Gene expression</subject><subject>Gene Expression Profiling</subject><subject>Gene Regulatory Networks - drug effects</subject><subject>Genes</subject><subject>Gynecology</subject><subject>Health aspects</subject><subject>HIV</subject><subject>HIV infections</subject><subject>HIV Infections - drug therapy</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Immune response</subject><subject>Immunologic Factors - pharmacology</subject><subject>Immunomodulation</subject><subject>In vitro methods and tests</subject><subject>Infections</subject><subject>Inflammation</subject><subject>Inflammation - pathology</subject><subject>Laboratories</subject><subject>Lymphocytes</subject><subject>Medical research</subject><subject>Medical schools</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbicides</subject><subject>Microbiota</subject><subject>Microbiota (Symbiotic organisms)</subject><subject>Models, Biological</subject><subject>Mucosa</subject><subject>Mucous Membrane - drug effects</subject><subject>Mucous Membrane - pathology</subject><subject>NF-kappa B - metabolism</subject><subject>NF-κB protein</subject><subject>Obstetrics</subject><subject>Oligonucleotide Array Sequence Analysis</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>Reproducibility of Results</subject><subject>Risk factors</subject><subject>Transcription, Genetic - drug effects</subject><subject>Vagina</subject><subject>Vagina - cytology</subject><subject>Vagina - microbiology</subject><subject>Vaginosis</subject><subject>Young adults</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk91u0zAUxyMEYmPwBggsISG4aLHzZYcLpFHGVmljCMZurVPnpPVI4mI7Y3tJnonTrZtWtAuUC0f27_zPd5I8F3wsMinenbnB99COl67HMRepKgr5INkWVZaOypRnD-_8byVPQjjjvMhUWT5OttKSF2mVltvJn33ske1dLD2GYF3PvnrX2Nb2c-YadjB00LNTmFvyxCbYtoFN6cJG79gnG4y3HT1FDGziuqUb-jqw3zYuVjKjad-00HUQnb9k0NfsaDAuwGi3jehXHghaoo8Ww3v2xZ1jyz5a14H_iT6wxnkC0FAs1pD3EwzxJqzpKTuyxruZNbZGNiFxW6_CeJo8aqAN-Gx97iQ_Pu-dTA5Gh8f708nu4ciUVRpHSkGTw6wSdUqFyERVCZVXKLnhM6w4ltKUKAQok8pCQKGUqJXIZcPpLLjMdpKX17rL1gW9bkXQolSlVCLLOBHTa6J2cKaXVCjwl9qB1VcXzs81UOqmRc2rGU8BqhzyNFeSQ1o1pcxnqHKOdS1I68Pa2zDrsDbYRw_thujmS28Xeu7OdZ4XlZKKBN6sBbz7NVAhdUfNo3ZCj264iltmJY1VReirf9D7s1tTc6AEbN848mtWono3F5JKVV65Hd9D0VdjZw3NLU0abhq83TAgJuJFnMMQgp5-__b_7PHpJvv6DrtAaOMiuHaINPFhE8yvQRquEDw2t0UWXK_W7qYaerV2er12ZPbiboNujW72LPsLM-IqKQ</recordid><startdate>20150608</startdate><enddate>20150608</enddate><creator>Zalenskaya, Irina A</creator><creator>Joseph, Theresa</creator><creator>Bavarva, Jasmin</creator><creator>Yousefieh, Nazita</creator><creator>Jackson, Suzanne S</creator><creator>Fashemi, Titilayo</creator><creator>Yamamoto, Hidemi S</creator><creator>Settlage, Robert</creator><creator>Fichorova, Raina N</creator><creator>Doncel, Gustavo F</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20150608</creationdate><title>Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates</title><author>Zalenskaya, Irina A ; Joseph, Theresa ; Bavarva, Jasmin ; Yousefieh, Nazita ; Jackson, Suzanne S ; Fashemi, Titilayo ; Yamamoto, Hidemi S ; Settlage, Robert ; Fichorova, Raina N ; Doncel, Gustavo F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-88af4ab91d205231991849e70c0be90e67c6e11a8c2751a5881d8147f01d85073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Activation</topic><topic>Anti-Infective Agents - pharmacology</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Bacteria</topic><topic>Bacteria - drug effects</topic><topic>Bacteria - growth &amp; development</topic><topic>Bioinformatics</topic><topic>Biology</topic><topic>Biomarkers</topic><topic>Biomarkers - metabolism</topic><topic>Cancer</topic><topic>Cell Line</topic><topic>Cellulose</topic><topic>Clinical trials</topic><topic>Cluster Analysis</topic><topic>Colony Count, Microbial</topic><topic>Comparative analysis</topic><topic>Data processing</topic><topic>Deregulation</topic><topic>Disease transmission</topic><topic>DNA microarrays</topic><topic>Drug Evaluation, Preclinical</topic><topic>Evaluation</topic><topic>Female</topic><topic>Functional analysis</topic><topic>Gene expression</topic><topic>Gene Expression Profiling</topic><topic>Gene Regulatory Networks - drug effects</topic><topic>Genes</topic><topic>Gynecology</topic><topic>Health aspects</topic><topic>HIV</topic><topic>HIV infections</topic><topic>HIV Infections - drug therapy</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Immune response</topic><topic>Immunologic Factors - pharmacology</topic><topic>Immunomodulation</topic><topic>In vitro methods and tests</topic><topic>Infections</topic><topic>Inflammation</topic><topic>Inflammation - pathology</topic><topic>Laboratories</topic><topic>Lymphocytes</topic><topic>Medical research</topic><topic>Medical schools</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbicides</topic><topic>Microbiota</topic><topic>Microbiota (Symbiotic organisms)</topic><topic>Models, Biological</topic><topic>Mucosa</topic><topic>Mucous Membrane - drug effects</topic><topic>Mucous Membrane - pathology</topic><topic>NF-kappa B - metabolism</topic><topic>NF-κB protein</topic><topic>Obstetrics</topic><topic>Oligonucleotide Array Sequence Analysis</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>Reproducibility of Results</topic><topic>Risk factors</topic><topic>Transcription, Genetic - drug effects</topic><topic>Vagina</topic><topic>Vagina - cytology</topic><topic>Vagina - microbiology</topic><topic>Vaginosis</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zalenskaya, Irina A</creatorcontrib><creatorcontrib>Joseph, Theresa</creatorcontrib><creatorcontrib>Bavarva, Jasmin</creatorcontrib><creatorcontrib>Yousefieh, Nazita</creatorcontrib><creatorcontrib>Jackson, Suzanne S</creatorcontrib><creatorcontrib>Fashemi, Titilayo</creatorcontrib><creatorcontrib>Yamamoto, Hidemi S</creatorcontrib><creatorcontrib>Settlage, Robert</creatorcontrib><creatorcontrib>Fichorova, Raina N</creatorcontrib><creatorcontrib>Doncel, Gustavo F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zalenskaya, Irina A</au><au>Joseph, Theresa</au><au>Bavarva, Jasmin</au><au>Yousefieh, Nazita</au><au>Jackson, Suzanne S</au><au>Fashemi, Titilayo</au><au>Yamamoto, Hidemi S</au><au>Settlage, Robert</au><au>Fichorova, Raina N</au><au>Doncel, Gustavo F</au><au>Garcia-Lerma, J. Gerardo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2015-06-08</date><risdate>2015</risdate><volume>10</volume><issue>6</issue><spage>e0128557</spage><epage>e0128557</epage><pages>e0128557-e0128557</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Inflammation and immune activation of the cervicovaginal mucosa are considered factors that increase susceptibility to HIV infection. Therefore, it is essential to screen candidate anti-HIV microbicides for potential mucosal immunomodulatory/inflammatory effects prior to further clinical development. The goal of this study was to develop an in vitro method for preclinical evaluation of the inflammatory potential of new candidate microbicides using a microarray gene expression profiling strategy. To this end, we compared transcriptomes of human vaginal cells (Vk2/E6E7) treated with well-characterized pro-inflammatory (PIC) and non-inflammatory (NIC) compounds. PICs included compounds with different mechanisms of action. Gene expression was analyzed using Affymetrix U133 Plus 2 arrays. Data processing was performed using GeneSpring 11.5 (Agilent Technologies, Santa Clara, CA). Microarraray comparative analysis allowed us to generate a panel of 20 genes that were consistently deregulated by PICs compared to NICs, thus distinguishing between these two groups. Functional analysis mapped 14 of these genes to immune and inflammatory responses. This was confirmed by the fact that PICs induced NFkB pathway activation in Vk2 cells. By testing microbicide candidates previously characterized in clinical trials we demonstrated that the selected PIC-associated genes properly identified compounds with mucosa-altering effects. The discriminatory power of these genes was further demonstrated after culturing vaginal cells with vaginal bacteria. Prevotella bivia, prevalent bacteria in the disturbed microbiota of bacterial vaginosis, induced strong upregulation of seven selected PIC-associated genes, while a commensal Lactobacillus gasseri associated to vaginal health did not cause any changes. In vitro evaluation of the immunoinflammatory potential of microbicides using the PIC-associated genes defined in this study could help in the initial screening of candidates prior to entering clinical trials. Additional characterization of these genes can provide further insight into the cervicovaginal immunoinflammatory and mucosal-altering processes that facilitate or limit HIV transmission with implications for the design of prevention strategies.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>26052926</pmid><doi>10.1371/journal.pone.0128557</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2015-06, Vol.10 (6), p.e0128557-e0128557
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1686781330
source MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS); EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Activation
Anti-Infective Agents - pharmacology
Anti-Infective Agents - therapeutic use
Bacteria
Bacteria - drug effects
Bacteria - growth & development
Bioinformatics
Biology
Biomarkers
Biomarkers - metabolism
Cancer
Cell Line
Cellulose
Clinical trials
Cluster Analysis
Colony Count, Microbial
Comparative analysis
Data processing
Deregulation
Disease transmission
DNA microarrays
Drug Evaluation, Preclinical
Evaluation
Female
Functional analysis
Gene expression
Gene Expression Profiling
Gene Regulatory Networks - drug effects
Genes
Gynecology
Health aspects
HIV
HIV infections
HIV Infections - drug therapy
Human immunodeficiency virus
Humans
Immune response
Immunologic Factors - pharmacology
Immunomodulation
In vitro methods and tests
Infections
Inflammation
Inflammation - pathology
Laboratories
Lymphocytes
Medical research
Medical schools
Microbial Sensitivity Tests
Microbicides
Microbiota
Microbiota (Symbiotic organisms)
Models, Biological
Mucosa
Mucous Membrane - drug effects
Mucous Membrane - pathology
NF-kappa B - metabolism
NF-κB protein
Obstetrics
Oligonucleotide Array Sequence Analysis
Real-Time Polymerase Chain Reaction
Reproducibility of Results
Risk factors
Transcription, Genetic - drug effects
Vagina
Vagina - cytology
Vagina - microbiology
Vaginosis
Young adults
title Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T19%3A06%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gene%20Expression%20Profiling%20of%20Human%20Vaginal%20Cells%20In%20Vitro%20Discriminates%20Compounds%20with%20Pro-Inflammatory%20and%20Mucosa-Altering%20Properties:%20Novel%20Biomarkers%20for%20Preclinical%20Testing%20of%20HIV%20Microbicide%20Candidates&rft.jtitle=PloS%20one&rft.au=Zalenskaya,%20Irina%20A&rft.date=2015-06-08&rft.volume=10&rft.issue=6&rft.spage=e0128557&rft.epage=e0128557&rft.pages=e0128557-e0128557&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0128557&rft_dat=%3Cgale_plos_%3EA417147678%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1686781330&rft_id=info:pmid/26052926&rft_galeid=A417147678&rft_doaj_id=oai_doaj_org_article_09b02aa94a424870a29f674be840edd1&rfr_iscdi=true